What is the appropriate emergency management for a patient experiencing an acute epileptic seizure, including safety measures, medication dosing, and follow‑up?

Emergency Management of Epileptic Seizures

For an acute epileptic seizure, immediately ensure patient safety by positioning them on their side, protecting the head, and clearing the surrounding area—then activate emergency services if the seizure lasts >5 minutes, occurs in water, involves trauma, or if this is a first-time seizure. 1

Immediate Safety Measures

During an active seizure:

• Help the person to the ground to prevent fall injuries
• Turn them onto their side in the recovery position to reduce aspiration risk
• Clear the area of hard or sharp objects
• Stay with the person throughout the seizure
• Never restrain the person or place anything in their mouth 1
• Do not give food, liquids, or oral medications during or immediately after the seizure 1

When to Activate Emergency Medical Services

Call EMS immediately for: 1

• First-time seizure
• Seizure lasting >5 minutes (status epilepticus)
• Multiple seizures without return to baseline between episodes
• Seizure occurring in water
• Associated traumatic injury, difficulty breathing, or choking
• Seizure in pregnancy
• Infant <6 months of age
• No return to baseline within 5-10 minutes after seizure stops

Pharmacologic Management of Status Epilepticus

First-Line Treatment: Benzodiazepines

Administer benzodiazepines immediately for seizures lasting >5 minutes. The evidence strongly supports benzodiazepines as first-line therapy, with intramuscular midazolam being preferred in the prehospital setting because it saves time and is at least as effective as intravenous lorazepam 2.

Critical pitfall: Many patients receive inadequate benzodiazepine doses—ensure optimal dosing before proceeding to second-line agents 2.

Second-Line Treatment: After Benzodiazepine Failure

If seizures continue despite optimal benzodiazepine dosing, immediately administer one of the following agents—they have equivalent efficacy (approximately 50-60% seizure cessation) and comparable safety profiles: 3, 4, 2

Choose based on patient-specific factors:

• Levetiracetam 30-50 mg/kg IV (up to 3000 mg) at 100 mg/min

  • Advantages: Minimal hypotension risk, no respiratory depression, safe profile
  • Disadvantages: Efficacy only 44-73% in various studies 3

• Valproate 20-30 mg/kg IV at 40 mg/min

  • Advantages: Superior to phenytoin in some studies (79% vs 25% for refractory cases), no hypotension risk 3
  • Disadvantages: Avoid in pregnancy, liver disease; risk of thrombocytopenia and hyperammonemia 3

• Fosphenytoin 18-20 PE/kg IV at 100-150 mg PE/min

  • Advantages: Traditional standard of care, widely available
  • Disadvantages: Only 56% efficacy, 12% hypotension risk, cardiac dysrhythmias, requires cardiac monitoring 3

The Neurocritical Care Society recommends any of these agents (valproate, levetiracetam, phenobarbital, or phenytoin/fosphenytoin) for urgent seizure control 3. The 2024 ACEP guidelines confirm no superiority among second-line agents, allowing individualized selection 4, 5.

Third-Line Treatment: Refractory Status Epilepticus

For seizures continuing after adequate first- and second-line therapy, escalate to anesthetic agents:

• Propofol 2 mg/kg bolus, followed by 5 mg/kg/hour infusion

  • Requires intubation and mechanical ventilation
  • Fewer ventilator days compared to pentobarbital 3

• Midazolam, barbiturates as alternatives 3

Important consideration: The European Federation of Neurological Societies recommends anesthetic doses of midazolam, propofol, or barbiturates for status epilepticus refractory to benzodiazepines and phenytoin, with 63% achieving seizure cessation 3.

Simultaneous Diagnostic Workup

While treating the seizure, immediately investigate reversible causes:

• Hypoglycemia (check fingerstick glucose)
• Hyponatremia and other electrolyte abnormalities
• Hypoxia
• Drug toxicity or withdrawal (alcohol, benzodiazepines)
• CNS infection (meningitis, encephalitis)
• Acute stroke or intracranial hemorrhage 3

Post-Seizure Management

After seizure termination:

• Monitor for return to neurologic baseline (typically 5-10 minutes)
• Maintain airway protection during postictal period
• Consider admission for first-time seizures, prolonged postictal state, or identified acute causes
• Arrange neurology follow-up for new-onset seizures

Special note on febrile seizures in children: Antipyretics (acetaminophen, ibuprofen) do not prevent or stop febrile seizures and should not be relied upon for seizure management 1.

Key Clinical Pitfalls to Avoid

1. Inadequate benzodiazepine dosing before declaring treatment failure 2
2. Delaying second-line agents while waiting for IV access—consider IM midazolam 2
3. Using phenytoin as sole second-line agent when alternatives with better safety profiles exist 3
4. Restraining patients or placing objects in mouth during active seizures 1
5. Missing nonconvulsive status epilepticus in patients with persistent altered mental status—consider EEG 6